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Abstract
Background: Connective Tissue Growth Factor (CTGF/CCN2), a known matrix-associated protein, is required for the
lactogenic differentiation of mouse mammary epithelial cells. An HC11 mammary epithelial cell line expressing
CTGF/CCN2 was constructed to dissect the cellular responses to CTGF/CCN2 that contribute to this differentiation
program.
Results: Tetracycline-regulated expression of CTGF/CCN2 in HC11 cells enhanced multiple markers of lactogenic
differentiation including b-casein transcription and mammosphere formation. In a separate measure of mammary
differentiation the addition of CTGF/CCN2 to cultures of MCF10A cells increased the development of acini in vitro.
In HC11 cells the elevated levels of CTGF/CCN2 diminished the requirement for extracellular matrix proteins in the
activation of b-casein transcription, indicating that CTGF/CCN2 contributed to lactogenic differentiation through
the regulation of matrix dependent cell adhesion. CTGF/CCN2 expression in HC11 cells increased expression of
extracellular matrix proteins and integrins, enhanced the formation of focal adhesion complexes, and increased
survival signaling. In addition, HC11 cells adhered to immobilized CTGF/CCN2 and this was inhibited by function-
blocking antibodies to the integrins a6 and b1, and to a lesser degree by antibody to b3 integrin.
Conclusions: CTGF/CCN2 expression in HC11 cells led to an increase in multiple markers of lactogenic
differentiation. The mechanisms by which CTGF/CCN2 contributed to lactogenic differentiation include direct
binding of CTGF/CCN2 to integrin complexes and CTGF/CCN2-induced matrix protein expression resulting in
elevated integrin functionality.
Background
The development of the mammary gland is hormonally
regulated [1], but the actions of locally-derived growth
factors and the interaction of mammary epithelial cells
with their surrounding stroma are also critical factors
for successful development [2]. Mammary epithelial cells
interact with the extracellular matrix predominantly
through the stromal components collagen and laminin
[3-5]. Lactogenic differentiation is associated with the
deposition of laminin-rich matrix by the epithelial cells
[6,7] and the degree of differentiation of mammary
epithelial cells correlates with their response to base-
ment membrane and stromal protein-induced signals. In
addition, the production of milk proteins by the
secretory epithelium is dependent on the presence of
specific mitogens [8-10], cell-cell contact [11,12], stimu-
lation by the lactogenic hormone prolactin [13-15], and
interaction with the extracellular matrix [7,16-18].
b1 integrin expression is required for the survival of
epithelial cells during differentiation [19] and it contri-
butes to mammary gland development and morphogen-
esis [20,21]. The interaction of b1 integrin with laminin
is critical for the initiation of the transcription of the
milk protein b-casein [22,23]. In addition, during lacto-
genic differentiation the activation of the prolactin
receptor ultimately results in the translocation of phos-
phorylated Stat5 dimers to the nucleus where they bind
DNA and regulate transcription [13,14,24], and integrin-
mediated adhesion is critical for the activation of Stat5
[25]. In vitro studies of the interaction between mam-
mary epithelial cells and basement membrane proteins
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the SWI/SNF transcription factor, Brg1, in translating
signals from the stroma to the activation of the b-casein
promoter [26].
Our previous work determined that Connective Tissue
Growth Factor (CTGF/CCN2), a known stromal media-
tor, is highly up-regulated during the lactogenic differ-
entiation of mouse mammary epithelial cells in a
glucocorticoid-dependent response [27,28]. That study
demonstrated that transient expression of CTGF/CCN2
enhanced b-casein transcription during the lactogenic
differentiation of mouse mammary epithelial cells and
that siRNA-mediated depletion of CTGF/CCN2 blocked
the process [27]. CTGF/CCN2 is a member of the CCN
family of matrix-associated proteins, which are known
to be involved in processes including the regulation of
growth, differentiation, migration and adhesion [29,30].
Members of the CCN family are comprised of 4 homol-
ogy domains: the N-terminal insulin-like growth factor
binding protein (IGFBP1) homology domain, followed
by the von Willebrand C (VWC) repeat domain, the
thrombospondin type 1 (TSP1) repeat domain, and the
C-terminal cysteine knot (CT) domain [31]. CTGF/
CCN2 is known to interact with b1 integrin complexes
through its TSP1 and C-terminal domains [32,33].
Because functional b1 integrin complexes are required
for lactogenesis in vivo and in vitro,o u rs t u d i e sf o c u s e d
on the effect of CTGF/CCN2 expression on this axis in
mammary epithelial cells.
The studies presented here employed HC11 mouse
mammary epithelial cells, a cell line capable of lacto-
genic differentiation in vitro [34-36], that has been
used in our previous studies [27,37,38]. HC11 cells are
non-transformed, immortalized, and undergo lacto-
genic differentiation upon stimulation with dexametha-
sone, insulin and prolactin [34,39]. To address the
mechanism by which CTGF/CCN2 contributes to the
regulation of lactogenic differentiation, CTGF/CCN2
was expressed under the control of a Tetracycline-
regulated promoter in HC11 cells. The results confirm
and extend our previous findings that CTGF/CCN2
mediates the enhancement of multiple markers of lac-
togenic differentiation in HC11 cells [27]. In addition,
ectopic expression of CTGF/CCN2 increased the for-
mation of focal adhesion complexes, integrin-mediated
survival signaling and cell adhesion. Hence, these find-
ings suggest that CTGF/CCN2 acts to stabilize the
cell-matrix interactions required for cell survival by
multiple mechanisms, and this translates directly and
indirectly into enhanced lactogenic differentiation as
measured by the subsequent phenotypic changes and
the transcription of b-casein.
Results
Ectopic CTGF/CCN2 expression enhanced the lactogenic
differentiation of HC11 cells
Previous studies conducted in our laboratory demon-
strated that CTGF/CCN2 was transcriptionally regulated
by the glucorticoid dexamethasone during the induction
of lactogenic differentiation in HC11 cells, and that ele-
vated CTGF/CCN2 expression was required for the dif-
ferentiation program [27]. To elucidate the mechanism
by which CTGF/CCN2 enhances the lactogenic differen-
tiation of mammary epithelial cells, a stable HC11-based
cell line was created by employing inducible expression
of CTGF/CCN2 under the control of a Tet-responsive
promoter (TRE). Analysis of these cells revealed that the
expression of vector-encoded CTGF/CCN2 readily
increased following the removal of doxycycline from the
culture media [27]. Following induction of CTGF/CCN2
expression in HC11 cells its effect on lactogenic differ-
entiation was evaluated by the addition of the lactogenic
hormone mixture of dexamethasone, insulin, and pro-
lactin (DIP) to the cultures. Known markers of lacto-
genic differentiation, including b-casein transcription
and mammosphere formation, were analyzed.
The formation of domed structures called mammo-
spheres occurs during lactogenic differentiation of HC11
cells in culture and serves as a phenotypic marker of
this process [40,41]. The effect of CTGF/CCN2 expres-
sion on mammosphere formation was examined follow-
ing stimulation of HC11-TRE-CTGF and the vector
control HC11-TRE cells with DIP for five days. The
HC11-TRE-CTGF cells displayed enhanced mammo-
sphere formation, both in the size (Figure 1A) and num-
ber (Figure 1B), compared to the identically treated
vector control cells.
The transcription of the milk protein b-casein is a
marker of lactogenic differentiation. Our previous stu-
dies demonstrated that transient expression of CTGF in
HC11 cells enhanced b-casein transcription compared
to control cells [27]. Hence, confluent cultures of HC11-
TRE-CTGF and HC11-TRE cells were stimulated with
lactogenic hormone and assayed for differentiation by
following b-casein transcription. Because endogenous
CTGF/CCN2 is rapidly induced by dexamethasone, a
component of the lactogenic hormone mix, the expres-
sion of b-casein RNA was examined in untreated cells
and prior to 24 hours of DIP treatment. At 0 and 8
hours post DIP stimulation the effect of vector-encoded
CTGF/CCN2 on this process (Figure 1C) was detected.
The results indicated a higher level of b-casein tran-
scription at 8 hours in the HC11-TRE-CTGF cells com-
pared to the HC11-TRE cells, confirming that CTGF/
CCN2 expression enhances transcription of b-casein in
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Page 2 of 15Figure 1 Ectopic CTGF/CCN2 expression in HC11 cells enhances lactogenic differentiation.( A) HC11-TRE and HC11-TRE-CTGF cells were
grown to confluence and exposed to DIP. The cells were photographed at 120 hrs post-DIP addition and are shown at 20× and 40×
magnification. The images shown representative of five fields. Mammospheres are bubble-like structures. (B) Mean is the result of the average
number of mammospheres in five low power microscopic fields. Data is expressed as the mean + S.D. (C) HC11-TRE and HC11-TRE-CTGF cells
were stimulated with DIP for 0, 8, or 16 hours. RNA was extracted and examined by Southern blotting. For quantitation, expression levels of b-
casein were normalized to actin and expressed as a fold induction of b-casein mRNA compared to the HC11-TRE control. (D) Chromatin
immunoprecipitation analysis of b-casein promoter. HC11-TRE and HC11-TRE-CTGF cells were grown in serum-free media for 24 hours prior to
being induced with DIP for 16 hours. (Top) PCR analysis of DNA immunoprecipitated with either an anti-Stat5 antibody or control IgG using
primers to amplify the b-casein promotor. (Bottom) Graphical analysis of PCR results from DNA immunoprecipitated with an anti-Stat5 antibody,
normalized to the amount of input DNA. Light columns = no DIP, dark columns = DIP (E) CTGF/CCN2 enhances the number and formation of
MCF-10A acini in Matrigel. MCF-10A cells were suspended in Matrigel and seeded on Matrigel in 8 well chamber slides. Cells were grown in the
absence or presence of CTGF/CCN2 (50 ng/ml) for 20 days. Images in depict acinar structures in culture by phase contrast microscopy at
magnificantion 10×. The cells were fixed and the nuclei stained with DAPI. Shown are serial confocal cross sections of acinar structures with
respect to the Z axis. The sequential sections reveal the hollow lumen (magnification 20×).
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CTGF/CCN2 expression resulted in low but detectable
b-casein in the absence of added lactogens (T = 0) sug-
gesting that a low level of lactogenic hormone, presum-
ably contributed by serum in the media, could induce
b-casein transcription in the presence of CTGF/CCN2.
The contribution of CTGF/CCN2 to b-casein promo-
ter activation was assessed by evaluating the binding of
Stat5 to the b-casein promoter via a chromatin immu-
noprecipitation assay (ChIP). Stimulation of HC11 cells
with prolactin activates Jak2 resulting in Stat5 phos-
phorylation, dimerization, nuclear translocation and
DNA binding. Control and CTGF-expressing HC11 cells
were stimulated with the lactogenic hormone mix for 24
hours. The treated cells were fixed in formaldehyde, the
nuclei were isolated and sonicated, and Stat5-DNA com-
plexes were recovered by immunoprecipitation. The
b-casein proximal promoter was amplified from the pur-
ified recovered DNA in order to determine the level of
Stat5 DNA binding. Results, shown in Figure 1D,
revealed that elevated CTGF/CCN2 expression led to a
modest but reproducible increase in the binding of Stat5
on the b-casein proximal promoter in the induced but
not the unstimulated cells. In repeated experiments (N
= 5) the outcome ranged from 1.25-2.1 fold greater
binding in TRE-CTGF than the TRE control cells. The
fact that detection of Stat5 promoter binding required
extended DIP-stimulation (i.e. 24 hours) diminished the
differences between the control and CTGF/CCN2-
expressing cells that were observed at the level of b-
casein RNA. However, this result supported the finding
of increased b-casein transcription in CTGF/CCN2-
expressing cells.
CTGF/CCN2 increased acinar formation by MCF10A cells
The formation of polarized acini-like spheroids that
mimic aspects of the architecture of the mammary
gland in vivo is a marker of differentiation for the
immortalized human mammary epithelial cell line
MCF10A [42]. The MCF10A cells form spheroids on
Matrigel and this is followed by apoptosis-driven clear-
ing of the lumen of these structures. The formation and
differentiation of the spheroids relies on integrin
engagement for the orientation and polarization of the
cells to form three dimensional structures. Because
CTGF/CCN2 expression enhanced the formation of the
HC11 cell domed mammospheres, the effect of CTGF/
CCN2 on the formation of the acinar structures by
MCF10A cells was examined. CTGF/CCN2 was supplied
to the MCF10A cells exogenously in a purified and solu-
ble form. In this assay MCF10A cells were suspended in
Matrigel in the presence or absence of CTGF/CCN2
and overlayed onto a solidified layer of Matrigel. The
cultures were maintained for 20 days, at which time the
cells were fixed, stained and analyzed by confocal micro-
scopy. The images, shown in Figure 1E, depict individual
DAPI-stained acinar structures in the presence or
absence of CTGF/CCN2 as sections from top to bottom
o ft h ea c i n u s .I n i t i a l l y ,t h ep r e s e n c eo fC T G F / C C N 2i n
the media enhanced both the size and the number of
the spheroid structures formed by the MCF10A cells.
However, over time the MCF10A cells cultured in the
presence of CTGF/CCN2 also exhibited a high level of
differentiation. This was characterized by a structured
epithelial cell layer surrounding a hollow lumen. Thus,
CTGF/CCN2 influenced the growth and differentiation
of both HC11 mouse mammary epithelial cells in two-
dimensional culture as well as MCF10A mammary
epithelial cells in three-dimensional culture.
CTGF/CCN2 functioned via matrix interaction during
b-casein transcription in HC11 cells
Previous studies have shown that CTGF/CCN2 acts as a
stromal mediator by binding to integrins and other
components of the extracellular matrix [43,44], and the
activation of b1 integrin complexes by matrix compo-
n e n t si sr e q u i r e df o rb-casein transcription and lacto-
genic differentiation [45]. Therefore, the effect of CTGF/
CCN2 on extracellular matrix regulation of b-casein
transcription was examined. HC11-TRE-CTGF and vec-
tor control cells were seeded on fibronectin-, collagen I-
, or Matrigel-coated or uncoated tissue culture dishes.
Following stimulation of the cells with lactogenic hor-
mone, RNA was extracted and used to analyze b-casein
expression by northern blot. Results are shown as the
fold induction of b-casein transcription in each cell line
grown on matrix proteins compared to the level of tran-
scription on plastic (Figure 2). The results demonstrated
a greater than 3-fold increase in b-casein transcription
in HC11-TRE vector control cells exposed to extracellu-
lar matrix components compared to tissue culture plas-
tic. In contrast, HC11-TRE-CTGF cells did not display a
significant increase of b-casein transcription when
g r o w no nf i b r o n e c t i n ,c o l l a g e nIo rM a t r i g e l .T h u s ,i t
appears that ectopic expression of CTGF/CCN2 partially
abrogates the influence of matrix components required
to initiate b-casein transcription. Moreover, the results
suggest that CTGF/CCN2 contributes significantly to
the collagen and laminin receptor engagement which is
required for the initiation of HC11 mammary epithelial
cell differentiation and b-casein transcription.
CTGF/CCN2 stimulation contributed to HC11 cell
proliferation and survival
CTGF/CCN2 increased mitogenesis in numerous types
of cells. Previously published data from our lab demon-
s t r a t e dt h a te l e v a t e de x p r e s s i o no fC T G F / C C N 2i n
HC11 cells resulted in enhanced expression of b1
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Page 4 of 15integrin and the activation of focal adhesion kinase
(FAK) [27]. Thus, to determine the contribution of
CTGF/CCN2 to integrin-mediated processes that effect
t h eg r o w t ho fH C 1 1c e l l s , CTGF/CCN2-expressing
HC11 cells were compared to vector control cells for
proliferative capacity in the absence of serum. The pro-
liferation was determined by MTT assay (Figure 3A)
and the results indicated HC11-TRE-CTGF cells dis-
played significantly more proliferative capacity than the
HC11-TRE vector control cells. In particular, prolifera-
tion was sustained by CTGF/CCN2 expression at later
times when the HC11 vector control cells ceased
proliferation.
CTGF/CCN2 is a secreted protein and approximately
half of the CTGF produced by the HC11-TRE-CTGF
cells is found in the media [27]. Therefore, conditioned
media from HC11-TRE-CTGF cells was harvested and
also used to determine the effect of CTGF/CCN2 on the
growth of HC11 cells. Results, shown in Figure 3B, indi-
cated that CTGF/CCN2-conditioned media sustained
the growth of HC11 cells longer than conditioned media
from HC11-TRE cells. Again, the most significant differ-
ences were observed at later time points. Together with
the effect of endogenously produced CTGF/CCN2, these
results suggest that CTGF/CCN2 played a role in the
proliferation of cells especially in the absence of serum.
However, neither HC11 vector control, nor HC11 cells
expressing or treated with CTGF/CCN2, proliferated in
the absence of EGF (data not shown). This indicated
that the effect(s) of CTGF/CCN2 in the HC11 cells dif-
fered from those of EGF on the same cells.
The apparent ability of CTGF/CCN2 to facilitate integ-
rin-mediated processes and proliferation, suggested a
role for CTGF/CCN2 in sustaining the survival of HC11
cells. Therefore, the effect of CTGF/CCN2 expression on
the ability of HC11 cells to progress through the cell
cycle in the absence of serum was examined. HC11-TRE
and HC11-TRE-CTGF cells were harvested following
96 hours in serum-free media, stained with propidium
iodide (PI) and analyzed by flow cytometry. Figure 4A
contains a cell cycle analysis comparison of the HC11-
TRE and HC11-TRE-CTGF cell lines. The data in Figure
4B indicate the percentage of total HC11-TRE and
HC11-TRE-CTGF cell populations in the sub G0/G1,G 1,
S, and G2/M phases of the cell cycle. In each cell line the
majority of cells were in the G1 phase of the cell cycle,
however, in support of the data suggesting sustained
growth of HC11 cells by CTGF/CCN2, the cells expres-
sing CTGF/CCN2 had greater percentage of the popula-
tion in both S and G2/M phases. In contrast, the
HC11-TRE vector control cells showed a greater popula-
tion of cells in sub G0/G1, which is indicative of possible
apoptosis. To determine the level of apoptosis, the cells
were examined for TUNEL, a measure of DNA fragmen-
tation characteristic of cells undergoing apoptosis. The
results, shown in Figures 4C, indicated a higher level of
TUNEL staining in HC11-TRE cells compared to the
HC11-TRE-CTGF cells.
Because CTGF/CCN2 enhanced the survival of HC11
cells, the contribution of CTGF/CCN2 to the activation
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interaction during lactogenic differentiation in HC11 cells.
HC11-TRE and HC11-TRE-CTGF cells were seeded in serum-free
conditions on respective coated or uncoated tissue culture dishes
and once confluent, induced to differentiate with DIP for 48 hours.
Total RNA was harvested and levels of b-casein transcript were
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Contribution of the matrix proteins to b-casein transcription can be
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Figure 3 CTGF/CCN2 stimulation contributes to HC11 cell
proliferation.( A) HC11-TRE and HC11-TRE-CTGF cells were seeded
in 96-well microtiter plates in serum-free media with EGF (10 ng/
ml). (B) HC11 cells were seeded in serum-free media with EGF (10
ng/ml) plus serum-free conditioned media from HC11-TRE or HC11-
TRE-CTGF (1:1 ratio). Cell proliferation was determined at 24, 48, 72,
and 96 hours post addition of EGF using the MTT assay. The results
are reported as the mean + S.D. of four determinations. *, p < 0.005.
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Page 5 of 15Figure 4 CTGF/CCN2 sustains the survival of mammary epithelial cells.( A) HC11-TRE and HC11-TRE-CTGF cells were seeded in serum-free
media in the presence of EGF (10 ng/ml) and harvested after 96 hours. Cells were fixed in ethanol and stained with propidium iodide (50 μg/
ml) prior to cell cycle analysis by flow cytometry. Data is representative of three determinations. Percentage of total gated cells in each phase of
the cell cycle is shown. (B) Graphical analysis of cell cycle distribution by DNA content in HC11-TRE cells or in HC11-TRE-CTGF cells. (C) HC11-TRE
and HC11-TRE-CTGF cells were seeded on coverslips in serum-free media in the presence of EGF (10 ng/ml) for 96 hours, then fixed and
apoptosis was detected by TUNEL. Left panels depict cell morphology, while the panels on the right display positive TUNEL staining in white.
Quantification of TUNEL staining is shown in panel below. (D) HC11-TRE and HC11-TRE-CTGF cells were seeded in serum-free media with EGF
(10 ng/ml). Lysates were harvested after 96 hours and the expression levels of the indicated survival proteins was analyzed by western blot.
Results are representative of 3 experiments.
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Protein lysates from HC11-TRE-CTGF and HC11-TRE
vector control cells were collected after 96 hours in
serum-free media and used to determine the expression
of mediators of integrin adhesion and survival signaling
(Figure 4D). The results indicated that HC11-TRE-
CTGF cells display enhanced expression of b1 integrin,
phosphorylated FAK, phosphorylated Akt, Bcl-xL and
cyclin D1 compared to expression levels in HC11-TRE
cells. The level of b3 integrin was slightly increased in
the CTGF-expressing cells as well (data not shown).
These results indicated that CTGF/CCN2 contributed to
integrin-mediated survival signaling in mammary epithe-
lial cells and implicated the b1-containing integrin com-
plex(es) in the control of both proliferation and survival
of HC11 cells.
CTGF/CCN2 increased integrin expression and function in
HC11 cells
CTGF/CCN2 bound to and enhanced the expression of
b1 integrin in other cell types [27,46], and the activation
of b1 integrin signaling is required for b-casein transcrip-
tion [47]. Hence, the degree to which the CTGF/CCN2-
mediated effects on cell proliferation and survival were
dependent on the CTGF/CCN2-induced integrin activa-
tion was tested. An MTT assay was performed in the pre-
sence of an integrin-binding RGD-containing peptide
that would be expected to act as a competitive inhibitor
for b1 integrin complexes including aVb1a n da5b1, as
well as aVb3. HC11-TRE and HC11-TRE-CTGF cells
were seeded in serum-free conditions with or without the
RGD peptide or control RAD peptide. Levels of prolifera-
tion were determined by MTT assay. Results, shown in
Figure 5A, displayed the expected enhanced proliferation
trend of HC11-TRE-CTGF cells compared to the vector
control HC11-TRE cells. The HC11-TRE-CTGF cells
incubated with the RGD peptide exhibited a 38% reduc-
tion in proliferative capacity at 96 hours, whereas the
RAD peptide showed no effect on the CTGF/CCN2-
enhanced proliferation of the cells. In contrast, the RGD
peptide inhibited growth of the TRE cells by 7% during
the same time period. Hence, while the control cells
express some endogenous levels of CTGF/CCN2, it is the
elevated expression of CTGF/CCN2 that provides a cell
adhesion and survival advantage, and targeting those
functions exposes the dependence on CTGF/CCN2 in
the TRE-CTGF cell line. These results suggested that the
RGD peptide partially blocked the integrin engagement
that occurred as a result of CTGF/CCN2 expression,
thereby affecting growth and survival.
CTGF/CCN2 interacts with the a6b1i n t e g r i nc o m -
plex in other cell types. a6b1 integrin is a common
mammary epithelial cell receptor for laminin [17] and
b1 is critical for mammary gland development in vivo
and milk protein synthesis in cultured mammary epithe-
lial cells [20,48]. To evaluate the effect of CTGF/CCN2
on the levels of expression of these integrins, HC11-
TRE and HC11-TRE-CTGF cells were incubated with
antibodies against surface level a6o rb1 integrin and
analyzed by flow cytometry. Results, shown in Figure
5B, indicated that HC11-TRE-CTGF cells displayed a
greater level of both a6 and b1 integrin on their surface
compared to the HC11-TRE control cells. Together
these results suggested that CTGF/CCN2 enhanced pro-
liferation and survival signaling through the stabilization
and activation of an a6b1 integrin complex or other a6
and b1 containing complexes.
HC11 cell adhesion to CTGF/CCN2 required integrin
complexes
CTGF/CCN2 is a secreted, integrin binding molecule.
To determine if CTGF/CCN2 was acting to mediate cell
adhesion, the ability of HC11 cells to attach to either
control or CTGF/CCN2-coated plates was tested.
HC11-TRE control cells were allowed to attach to
recombinant CTGF/CCN2-coated microtiter wells for 4
hours. Adherent cells were fixed and stained and the
absorbance at 570 nm was determined for quantitation
of cell adhesion. A significant increase in the adhesion
of cells seeded on CTGF/CCN2-coated wells was
observed compared with cells seeded on the BSA-coated
control wells (Figure 6A). The adhesion was inhibited
by the inclusion of EDTA, and rescued with the addition
of Mg
2+, indicative of the interaction required for
CTGF/CCN2-integrin-mediated attachments [49].
To determine if the a6b1 integrin complex was
involved in the CTGF/CCN2-mediated enhancement of
adhesion, the adhesion assay was performed in the pre-
sence of function blocking antibodies against both a6
and b1 integrins. CTGF/CCN2 also binds aVb3 so func-
tion blocking antibodies against ava n db3i n t e g r i n s
were tested as well (Figure 6B). The addition of the
anti-a6o ra n t i - b1 antibodies completely blocked the
CTGF/CCN2-mediated increase in adhesion while
the addition of the anti-b3 showed less inhibition, and
the anti-aV or isotype control antibodies showed no sig-
nificant change in CTGF/CCN2-mediated adhesion.
Together with the flow cytometry data demonstrating
the CTGF/CCN2-mediated enhancement of surface
level expression of the a6b1 integrin complex, these
results confirmed the involvement of the a6b1i n t e g r i n
complex in the CTGF/CCN2-mediated increase in
HC11 cell adhesion.
CTGF/CCN2 expressing cells displayed increased
formation of focal adhesions
Interactions between mammary epithelial cells and the
basement membrane are crucial for survival. To further
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stabilization of b1 integrin complexes on the formation
of focal adhesion complexes, the level and the appear-
ance of focal adhesion and extracellular matrix proteins
were analyzed. Protein lysates from HC11-TRE and
HC11-TRE-CTGF cells were used for determination of
specific protein expression by western blot (Figure 7A).
Results revealed increases in the focal adhesion-asso-
ciated adaptor and structural proteins in HC11-TRE-
CTGF cells including paxillin, p130CAS, vinculin,
parvin, PINCH1, and Rsu-1 [50]. Furthermore, HC11-
TRE-CTGF cells displayed increases in Src but not
integrin linked kinase (ILK). Elevated transcription of
collagen, laminin and fibronectin was detected in HC11
Figure 5 CTGF/CCN2 contributes to the stabilization of surface-level integrin complexes.( A) HC11-TRE and HC11-TRE-CTGF cells were
incubated in serum-free media with EGF (10 ng/ml) or identical media containing either an RGD-containing peptide or RAD-containing peptide
(500 μM). The MTT assay was performed at 24, 48, 72, and 96 hours. The results are displayed as the mean + the S.D. of four determinations.
*, p < 0.005. (B) HC11-TRE and HC11-TRE-CTGF cells were grown in serum free media for 4 days in the presence of EGF (10 ng/ml). Cells were
harvested and stained with an anti-b1 integrin antibody, anti-a6 antibody or isotype controls followed by detection with a fluorescence-
conjugated secondary antibody and analysis by flow cytometry. The median number of b1 integrin or a6 positive cells is indicated. The data are
representative of 4 independent experiments.
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Page 8 of 15TRE-CTGF cells compared to the TRE control cell line
(data not shown) and elevated fibronectin was detected
in HC11-TRE-CTGF cells by western blot (Figure 7B).
Immunofluorescent staining of the cells with an anti-
body to vinculin revealed greater focal adhesion forma-
tion, both in size and number, in HC11-TRE-CTGF
cells compared to vector control HC11-TRE cells (Fig-
ure 7B), demonstrating thef u n c t i o n a l i t yo fC T G F /
CCN2 on integrin-dependent formation of focal adhe-
sions in HC11 mammary epithelial cells.
In conclusion, these results indicated that the mechan-
ism by which CTGF/CCN2 contributed to lactogenic
differentiation was via activation of integrin-mediated
adhesion complex(es), particularly the a6b1c o m p l e x ,
which enhanced cell adhesion and survival in HC11
cells. This could be attributed to direct binding of
CTGF/CCN2 to integrin complexes and to CTGF/
CCN2-induced laminin and fibronectin expression. Both
events would be expected to result in elevated integrin
expression and functionality. Because the engagement of
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Figure 6 CTGF/CCN2 enhances adhesion of HC11 cells through the a6b1 integrin complex. HC11-TRE cells were resuspended in serum-
free growth media + EGF (10 ng/ml) and seeded on microtiter wells coated with recombinant CTGF/CCN2 (2 μg/ml) or 1% BSA wells as
described in Methods. Adherent cells were fixed , stained, and quantified by reading the absorbance at 570 nm. Data are means of
quadruplicate samples, error bars represent standard error. *, ◇, ■, p < 0.005. (A) HC11-TRE cells adhesion in serum-free growth media + EGF
(10 ng/ml) with EDTA (2.5 mM), EDTA + Mg2+ (5 mM) or no addition. (B) HC11-TRE cells adhesion in serum-free growth media + EGF (10 ng/ml)
with function-blocking antibodies or isotype controls (25 μg/ml).
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Page 9 of 15b1 integrin is required for the transcription of b-casein
and lactogenic differentiation of the mammary gland,
these results suggest an important role for CTGF/CCN2
in mammary epithelial cell function.
Discussion and Conclusions
Stromal mediators play a fundamental role in promoting
mammary differentiation, and the contact between
mammary epithelial cells and components of the base-
ment membrane contributes to the prolactin-induced
transcription of milk proteins [47]. Using the Tet-off
system for inducible CTGF/CCN2 expression in the
HC11 mouse mammary epithelial cell background,
CTGF/CCN2 not only enhanced the early transcription
of b-casein in response to lactogenic hormone, but also
contributed to the formation of mammospheres, a hall-
mark of terminal differentiation in these cells. In addi-
tion, exogenous CTGF/CCN2 enhanced the formation
of differentiated MCF10A acini in three dimensional
cultures, extending the role of CTGF/CCN2 to another
A B
HC11-TRE HC11-TRE-CTGF
Vinculin
p130cas
Paxillin
ILK
Parvin
Vinculin
Src
PINCH
Rsu-1
Actin
HC11-
TRE
HC11-
TRE-CTGF
Fibronectin
Figure 7 CTGF/CCN2 contributes to the formation of focal adhesion complexes in HC11 cells.( A) HC11-TRE and HC11-TRE-CTGF cell
protein lysates were used to detect levels of the indicated focal adhesion-related proteins by western blot. (B) HC11-TRE and HC11-TRE-CTGF
cells were seeded in 0.5% serum-containing media with EGF (10 ng/ml) for 4 days. The cells were then fixed in paraformaldehyde and stained
for the presence of vinculin with Alexaflor488-conjugated secondary antibody and a DAPI nuclear counterstain. In the vinculin panel focal
adhesions are shown as punctate bodies primarily near the edges of cells. Magnification = 40×.
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siologically relevant to the in vivo setting [42]. The role
of CTGF/CCN2 in lactogenic differentiation may
depend on its function in the expression and stabiliza-
tion of matrix-integrin complexes, an activity which pro-
motes prolactin-induced Stat5 activity.
The data reported here suggest that CTGF/CCN2
increased expression of fibronectin and laminin and sta-
bilized the surface expression of the a6 and b1 integrins.
Typically, epithelial cells lose their ability to survive in
the absence of serum and detach, initiating an apoptotic
process called anoikis. However, CTGF/CCN2 served as
a survival mediator thereby preventing HC11 cells from
undergoing apoptosis in the absence of serum. The
binding of integrins to matrix proteins promotes confor-
mational changes in the extracellular domains of the
integrins and a subsequent clustering of integrins in
focal adhesions. Survival signaling resulting from the
formation of focal adhesion complexes involves p130cas,
paxillin, ILK, and Src [51]. The complex is formed after
adhesion-induced phosphorylation of FAK-Y397.
Recruitment of Src causes tyrosine phosphorylation of
additional sites on FAK, and FAK-mediated phosphory-
lation of p130cas and paxillin [52]. FAK activation may
also contribute to cell survival by direct activation of the
P-I-3 kinase/Akt pathway [53]. CTGF/CCN2 expression
correlated with enhanced expression levels of the major
proteins involved in the focal adhesions referred to
above, as well as PINCH1 and Rsu-1, which localize to
focal adhesion complexes [54,55]. Anti-vinculin immu-
nofluorescence visualized larger focal adhesions in
CTGF/CCN2-expressing cells compared to control
HC11 cells. These results confirm a role for CTGF/
CCN2 in the stabilization of active integrin-mediated
complexes and adhesion-activated survival signaling.
This is likely linked to the CTGF/CCN2-mediated adhe-
sion signaling via integrins and the activation of Akt
and expression of Bcl-xL. However, HC11 cells expres-
sing CTGF/CCN2 also exhibited elevated levels of Map
kinase phosphatase1 (MKP-1) (data not shown), a dual
specificity phosphatase frequently induced in response
to Map Kinase signaling. MKP-1 dephosphorylates p38
kinase, suggesting that preventing the accumulation of
phospho-p38 may be a contributing mechanism by
which CTGF/CCN2 inhibits apoptosis.
CTGF/CCN2-mediated activation of b1i n t e g r i ns i g -
naling has been demonstrated in primary skin fibroblasts
[56] and activated pancreatic stellate cells [46]. In fibro-
blasts CTGF/CCN2 also induced expression of the
extracellular matrix proteins laminin, collagen, fibronec-
tin and integrin subunits [57], similar to the increase in
these proteins that was observed in the HC11 cells engi-
neered to express CTGF/CCN2. The elevated expression
of fibronectin and laminin would be expected to the
increase integrin engagement and focal adhesion forma-
tion. Moreover, Cyr61/CCN1 and Nov3/CCN3, highly
homologous members of the CCN family, have been
s h o w nt ob i n dt oa n de n h a n c eb1 integrin-mediated
functions in primary skin fibroblasts [49,58]. In our
study enhanced integrin-dependent signaling may have
resulted from direct interaction between integrins and
secreted or cell-bound CTGF/CCN2, as suggested by
the integrin blocking antibody data in Figure 6. In addi-
tion, the elevation of matrixp r o t e i ne x p r e s s i o nm a y
have increased RGD-binding integrin engagement in
HC11 cells and this likely contributed to enhanced pro-
liferation and survival of HC11 TRE-CTGF cells in the
absence of serum. Another contribution may result from
elevation of syndecan 4, a heparin sulfate proteoglycan,
which has been reported to stabilize integrin complexes,
including b1 integrin complexes [59]. Syndecan 4 upre-
gulation has been observed in CTGF/CCN2-stimulated
or -expressing cells [60,61], and the HC11-TRE-CTGF
cells also express elevated levels of syndecan 4 compared
to the HC11-TRE vector control cell line (data not
shown).
The association of mammary epithelial cells with lami-
nin is critical for the activation and the nuclear translo-
cation of Stat5 [25]. Association of the cells with the
matrix proteins occurs through active binding to b1
integrin complexes on the cell surface. It is known that
binding to laminin via the b1 integrin complex [3] is
directly associated with the induction of lactogenesis
and b-casein transcription [5], although the a integrin
has not been definitely identified [62,21]. Our data indi-
cate that CTGF/CCN2 enhances the expression of lami-
nin resulting in decreased requirement for exogenous
laminin in the activation of b-casein transcription, as
seen in Figure 2. CTGF/CCN2 expressing cells did not
display the same laminin-dependent increase in the level
of b-casein mRNA as control cells, suggesting that
CTGF/CCN2 partially abrogates the requirement for
those proteins for the transcription of b-casein. Collec-
tively, these results suggest that the mechanism by
which CTGF/CCN2 enhances lactogenic differentiation
is through enhancement and stabilization of the lami-
nin- a6b1 integrin cell-matrix interaction that is
required early in the lactogenic differentiation process.
The adhesion of epithelial cells to extracellular matrix
initiates signaling mechanisms that control cell prolifera-
tion, survival, and differentiation throughout the phases
of mammary gland development. Our finding that ecto-
pic expression of CTGF/CCN2 enhanced the growth and
survival of HC11 cells in vitro supports a proposed role
for CTGF/CCN2 during late pregnancy and early lacta-
tion, a period when CTGF/CCN2 levels are elevated in
vivo [27,28]. While this study focused on the mechanism
of CTGF/CCN2 in HC11 mouse mammary epithelial
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casein in primary mouse mammary epithelial cells stimu-
lated to differentiate [27]. Recent mammary specific
knockdown studies ascertained that b1 integrin as well as
FAK and Src contribute to the development of the mam-
mary gland and the induction of lactogenesis [22,63,64].
Mammary specific inhibition of b1 integrin reduced the
activation of the MAPK and Akt and ultimately resulted
in diminished mammary growth and increased mammary
developmental defects [20,63]. Similarly, a mammary spe-
cific knockout of FAK caused tissue defects as well as a
reduction in milk protein production; this was attributed
to a diminished secretory capacity of the epithelium due
to the combination of decreased proliferative ability and
a lack of Stat5 activation [22]. Moreover, a knockout of
Src blocked lactational ability of the mammary gland
although the gland maintained otherwise normal growth
[64]. Based on the results reported here, the effects of a
mammary specific knock down of CTGF/CCN2 may
prove useful in understanding the control of lactogenic
differentiation in vivo.
Methods
Cell culture and the construction of CTGF Tet-off cell line
HC11 mouse mammary epithelial cells, provided by Dr.
Nancy Hynes, were maintained in RPMI 1640 medium
supplemented with 10% fetal bovine serum, 5 μg/ml
insulin, 10 mM HEPES and 10 ng/ml EGF as described
[13,35]. The HC11 cell line containing the pTet-Off
plasmid (Clontech, Mountainview, CA) was infected
with a pREV-TRE (Clontech) retroviral vector encoding
epitope-tagged CTGF/CCN2 and used to express HA-
CTGF/CCN2 in response to removal of doxycycline
(Dox) as described previously [27]. The HC11-TRE vec-
tor control cells and HC11-TRE-CTGF cells were grown
in doxycycline (2 μM) which was removed for 96 hours
to induce CTGF/CCN2 expression for experiments.
Prior to stimulation with lactogenic hormones, HC11
cells and HC11-derived cell lines were grown to conflu-
ence and maintained for 3-5 days to establish compe-
t e n c e[ 9 , 3 9 ]t h e nm a i n t a i n e di nm e d i aw i t h o u tE G Ff o r
24 hours. To induce lactogenic hormone-induced differ-
entiation, the cells were rinsed twice and then incubated
in differentiation media, RPMI with dexamethasone
(10
-6M), 5 μg/ml insulin, and 10 μg/ml prolactin,
referred to as DIP. Lactogenic differentiation was char-
acterized by analysis of b-casein transcription and by
the formation of domed structures referred to as mam-
mospheres, which were visualized by phase contrast
microscopy and manually enumerated.
MCF10A acinus formation
Acinus formation was performed with MCF10A cells
using an established technique with minor modifications
[42]. Growth factor reduced Matrigel was added to wells
of an eight-well glass chamber slide. Basement mem-
brane was allowed to solidify for 15 minutes at 37°C.
MCF-10A cells were harvested, washed in DMEM/F12,
2% horse serum and resuspended in assay media
(DMEM/F12, 2% horse serum, 0.5 μg/ml hydrocortisone,
100 ng/ml cholera toxin, 10 μg/ml insulin). A mixture of
assay media containing EGF (20 ng/ml) plus 4% Matri-
gel was prepared with or without CTGF/CCN2 (25-100
ng/ml, Cell Sciences, Canton, MA). A 1:1 mixture of the
Matrigel-containing assay media and MCF-10A cells
(25,000 cells/ml) was plated on top of the solidified
basement membrane. The cells were incubated at 37°C
for 20 days with media changes every 4 days. Each well
was fixed with 2% paraformaldehyde followed by per-
meabilization in 0.5% Triton X-100 at 4°C. Wells were
then rinsed with PBS containing glycine (100 mM) and
blocked with IF buffer (7.7 mM sodium azide, 0.1%
BSA, 0.2% Triton X-100, 0.05% Tween-20, 10% FBS).
The cells were washed in PBS and mounted to slides
with ProLong Gold antifade reagent containing DAPI
(Molecular Probes, Invitrogen, Eugene, OR). Confocal
imaging was performed on a Zeiss Pascal Laser Scan-
ning Confocal Microscope (Carl Zeiss, Thornwood, NY).
RNA isolation, RT-PCR, northern blotting, and Southern
blotting
Total RNA was isolated and purified using the TriPure
reagent (Roche, Palo Alto, CA). Northern blots were pre-
pared with 10 μg of total RNA separated on a 1% agarose-
formaldehyde gel and transferred to a nylon filter. Reverse
transcriptase PCR (RT-PCR) was performed using the
GeneAmp RNA PCR Kit and primers for b-casein amplifi-
cation as follows: Fwd 5’ CATCCTTTCAGCTTCACC,
Rev 5’ AGAGACAGCTGGGTCTGAG. Primers for
mouse b-actin were as follows: Fwd 5’ CTAAGGC-
CAACCGTGAAAAGA, Rev 5’ GAGGTCTTTACG-
GATGTCAAC. PCR products were electophoresed on a
1% agarose gel. The DNA was denatured and neutralized
and transferred to a nylon filter. Northern and Southern
blots were hybridized as described previously [27]. The
probes for CTGF, b-casein and actin have been described
[27,37].
Chromatin Immunoprecipitation
Confluent HC11-TRE and HC11-TRE-CTGF cells were
stimulated with DIP for 16 hours prior to cross-linking
with 1% formaldehyde for 10 minutes at room tempera-
ture, followed by treatment with 1.12 ml of 2.5 M gly-
cine for 5 minutes at room temperature. The
precipitating antibodies used included anti-rabbit IgG
(Chemicon, PP64) or anti-Stat5 N-term (Santa Cruz, sc-
836). Primers for the b-casein proximal promoter, for-
ward 5’CCAGCTTCTGAATTGCTGCC3’,r e v e r s e
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reactions of 35 cycles of 1 minute at 95°C, 30 seconds at
55°C, 30 seconds at 72°C. Amplified DNA was analyzed
by electrophoresis on an ethidium bromide stained 1.5%
agarose gel. Bands were quantitated using the Fujifilm
LAS-4000 (Fujifilm Medical Systems USA, Inc.). Results
are expressed as a ratio of immunoprecipitated DNA to
the input DNA.
Western blotting and Immunoprecipitation
The procedures for western blotting have been
described [27,37,38,55]. The antibodies used in this
study include: mouse anti-b-actin (Sigma, St. Louis,
MO), goat anti-CTGF (Santa Cruz Biotechnology, Santa
C r u z ,C A ) ,m o u s ea n t i - b1i n t e g r i n( B DT r a n s d u c t i o n ,
BD Biosciences, San Diego, CA), mouse anti-FAK (BD
Transduction), rabbit anti-phospho-FAK (Upstate Tech-
nologies), rabbit anti-Akt (Cell Signaling Technolgies,
Danvers, MA ), rabbit anti-phospho-Akt (Cell Signaling
Technology), rabbit anti-Bcl-xL (Santa Cruz Biotechnol-
ogy), mouse anti-PINCH1 (BD Transduction), rabbit
anti-ILK (Santa Cruz Biotechnology), rabbit anti-acto-
paxin/parvin (Sigma), mousea n t i - p 1 3 0 C A S( U p s t a t e
Technologies), mouse anti-paxillin (BD Transduction),
rabbit anti-c-src (Santa Cruz Biotechnology), mouse
anti-vinculin (Sigma). The rabbit anti-Rsu-1 antibody
has been described [55].
Immunofluorescence
To detect focal adhesions, HC11-TRE and HC11-TRE-
CTGF cells were grown in the absence of doxycycline
for 4 days, at which time they were seeded on coverslips
and maintained in serum-free media + EGF (10 ng/ml)
for 4 days. The cells were washed with PBS, fixed in 4%
paraformaldehyde then permeabilized with 0.5% Triton
X-100 and blocked in 4% BSA prior to an overnight
incubation at 4°C with an anti-vinculin antibody
(Sigma). Coverslips were washed with PBS and incu-
bated for 30 minutes in the dark at room temperature
with an AlexaFluor 488-conjugated secondary antibody
then mounted with ProLong Gold antifade reagent con-
taining DAPI (Molecular Probes, Invitrogen, Eugene,
OR). Immunofluorescence was visualized using an
Olympus IX71 microscope, a QImaging Retiga 2000RV
camera, and QCapture Pro 6.0 software (Olympus
America Inc, Center Valley, PA).
MTT and TUNEL Assays
Proliferation of HC11-TRE-CTGF and vector control
HC11-TRE cells was determined by MTT assay (CellTi-
t e r 9 6A s s a y ,P r o m e g a ,M a d i s o n ,W I ) .V i a b l ec e l l sg r o w n
in the absence of doxycycline for 96 hours were replated
at a density of 1.5 × 10
4 per well in quadruplicate wells of
a 96-well plate in serum-free media with EGF (10 ng/ml).
HC11-TRE cells were analyzed following exposure to
conditioned media from HC11-TRE-CTGF cells, and in
the presence of RGD- or RAD-containing peptide (500
μM ,B i o M o l ,P l y m o u t hM e e t i n g ,P A ) .T h ec e l l sw e r e
incubated for 24, 48, 72, or 96 hours. Analysis of the
MTT assay has been described previously [37].
Apoptosis was detected in vector control HC11-TRE
cells and HC11-TRE-CTGF cells by TUNEL technology
(In Situ Cell Death Detection Kit, Fluorescein, Roche).
Cells previously grown in the absence of doxycycline for
96 hours were grown on coverslips in serum-free media
in the presence of EGF (10 ng/ml) for 96 hours. The
cells were fixed in 4% paraformaldehyde, permeabilized
in 0.1% Triton X-100 on ice, and rinsed in PBS and
incubated in 50 μl TUNEL reagent for 1 hour at 37°C in
the dark. The cells were rinsed in PBS prior to being
mounted on slides (Vectashield mounting media, Vector
Labs, Burlingame, CA). Cells were viewed on the Olym-
pus BX61 and analyzed by IVision software (IVision,
Atlanta, GA).
Flow cytometry
Cell cycle analysis and surface level expression of a6 and
b1 integrins were determined by flow cytometry. HC11-
TRE and HC11-TRE-CTGF cells grown without doxycy-
cline for 96 hours were propagated for 96 hours in serum-
free media with EGF (10 ng/ml). The cells were harvested
with Cell Stripper (Mediatech, Manassas, VA), pelleted,
washed, and counted. For cell cycle analysis, cells were
resuspended in PBS and methanol was added dropwise for
fixation prior to storage at -20°C for 24-96 hours. The
cells were pelleted and resuspended in cold PBS and pro-
pidium iodide (50 μg/ml) was added to the cells prior to
flow cytometric analysis. For integrin expression analysis,
the cells were aliquoted into 1 ml samples of 500,000 cells
each and washed in FACS wash buffer (1% FBS, 0.05%
sodium azide). Cells were then incubated in buffer with
antibodies against b1 integrin (BD Biosciences) or a6
integrin (BD Biosciences) or the isotype controls for 1
hour at 4°C then pelleted and resuspended FACS buffer
containing PE- or FITC- conjugated secondary antibodies
for 45 minutes at 4°C. The cells were fixed in Cytofix (BD
Biosciences) on ice, washed and resuspended in FACS buf-
fer. All flow cytometry was performed using a BD Bios-
ciences LSRII cytometer. Cell cycle analysis was
performed using ModFit LT software and integrin expres-
sion analysis was performed using WinList software (Ver-
ity Software House Inc.).
CTGF/CCN2 adhesion assay
To determine the interaction between CTGF/CCN2
and integrin complexes, HC11-TRE cells were seeded
in serum-free media + EGF (10 ng/ml) on maleic
anhydride Reacti-Bind microtiter wells (Thermo
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CCN2 protein (Cell Sciences, Canton, MA). The plates
were coated with CTGF/CCN2 (2 μg/ml) overnight at
4°C, followed by blocking with 1% BSA for 2 hours at
37°C. HC11-TRE cells were suspended at a concentra-
tion of 5 × 10
5 cells/ml, and where indicated mixed
with EDTA (2.5 mM), EDTA (2.5 mM) + Mg
2+,b l o c k -
ing antibodies to aV, b3 (Santa Cruz Biotechnologies),
a6, or b1 integrins (BD Biosciences), or isotype control
antibodies. Cells were allowed to attach for 4 hours at
37°C, washed gently with PBS and fixed with 3.7% for-
maldehyde for 10 minutes at room temperature. Fixed
cells were washed with stained with crystal violet and
the adherent cells were quantified by reading the
absorbance at 570 nm.
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